Establishment Labs/$ESTA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Establishment Labs
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.
Ticker
$ESTA
Sector
Primary listing
Employees
1,056
Headquarters
Alajuela, Costa Rica
Website
ESTA Metrics
BasicAdvanced
$1.1B
-
-$3.08
0.83
-
Price and volume
Market cap
$1.1B
Beta
0.83
52-week high
$47.86
52-week low
$26.56
Average daily volume
386K
Financial strength
Current ratio
2.838
Quick ratio
1.545
Long term debt to equity
986.236
Total debt to equity
986.236
Interest coverage (TTM)
-2.72%
Profitability
EBITDA (TTM)
-54.028
Gross margin (TTM)
67.24%
Net profit margin (TTM)
-49.89%
Operating margin (TTM)
-35.43%
Effective tax rate (TTM)
-1.17%
Revenue per employee (TTM)
$170,000
Management effectiveness
Return on assets (TTM)
-12.78%
Return on equity (TTM)
-261.18%
Valuation
Price to revenue (TTM)
6.339
Price to book
49.76
Price to tangible book (TTM)
109.25
Price to free cash flow (TTM)
-14.002
Free cash flow yield (TTM)
-7.14%
Free cash flow per share (TTM)
-2.793
Growth
Revenue change (TTM)
17.22%
Earnings per share change (TTM)
-0.62%
3-year revenue growth (CAGR)
7.21%
3-year earnings per share growth (CAGR)
1.19%
What the Analysts think about ESTA
Analyst ratings (Buy, Hold, Sell) for Establishment Labs stock.
Bulls say / Bears say
Q2 2025 revenue grew 16.3% year-over-year to $51.3 million, driven by strong U.S. Motiva sales of $10.3 million which beat analyst expectations (Reuters).
Management raised full-year 2025 revenue guidance to $208 million–$212 million, up from $205 million–$210 million, and maintained expectations of positive EBITDA in 2025 and cash-flow positivity by 2026 (Reuters).
Second-quarter gross margin expanded to 68.8% from 65.6% a year ago, reflecting favourable geographic mix and higher average selling prices (Reuters).
Net loss widened to $16.59 million in Q2 2025, missing analyst estimates of $15.90 million and reflecting a deeper operating loss of $14.11 million versus an expected $10.60 million loss (Reuters).
Increased SG&A expenses from U.S. commercial investments led to wider operating losses in Q2 2025, undermining profitability despite strong revenue growth (Reuters).
Q2 2025 EPS of -$0.57 fell short of the consensus -$0.53 estimate, highlighting ongoing margin pressure and execution risks (Reuters).
Data summarised monthly by Lightyear AI. Last updated on 8 Sept 2025.
ESTA Financial Performance
Revenues and expenses
ESTA Earnings Performance
Company profitability
ESTA News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Establishment Labs stock?
Establishment Labs (ESTA) has a market cap of $1.1B as of September 18, 2025.
What is the P/E ratio for Establishment Labs stock?
The price to earnings (P/E) ratio for Establishment Labs (ESTA) stock is 0 as of September 18, 2025.
Does Establishment Labs stock pay dividends?
No, Establishment Labs (ESTA) stock does not pay dividends to its shareholders as of September 18, 2025.
When is the next Establishment Labs dividend payment date?
Establishment Labs (ESTA) stock does not pay dividends to its shareholders.
What is the beta indicator for Establishment Labs?
Establishment Labs (ESTA) has a beta rating of 0.83. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.